Home
Advertisement & Sponsorship Options
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
Advertisement & Sponsorship Options
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Home
Clinical development
Page 21
Clinical development
Clinical Development
US FDA Approves Gilead’s Sacituzumab Govitecan In Pre-treated HR+/HER2- Metastatic Breast Cancer
Editorial Team
-
February 3, 2023
Study: Blocking Immune Suppressor Cells in Mice with Glioblastoma Improves Survival
Investigational Therapy Shows Promise Against Viral Infections After Stem Cell Transplant
Phase 2b Study Investigates NFX-179 for the Treatment of Cutaneous Neurofibromas
First Patient Randomized in Phase 3 Study Evaluating Radioenhancer NBTXR3 in Head and Neck Cancer
Study Shows Urine-based Liquid Biopsy Outperforms Urine Cytology in Detecting Bladder...
Editorial Team
-
October 9, 2020
Disitamab Vedotin Receives FDA Breakthrough Therapy Designation for Treatment of Urothelial...
Peter Hofland, Ph.D
-
September 25, 2020
Japan Approves Cetuximab Saratolacan in Unresectable Locally Advanced/Recurrent Head & Neck...
Peter Hofland, Ph.D
-
September 25, 2020
Astellas Establishes Global Patient-centricity Leadership: Includes Patient Perspective in Research
Peter Hofland, Ph.D
-
September 23, 2020
Lantern Pharma and Fox Chase Cancer Center Collaborate in Developing LP-184...
Editorial Team
-
September 22, 2020
ESMO 2020: Derazantinib in Preclinical Models with FGFR Aberrations Supports Gastric...
Peter Hofland, Ph.D
-
September 22, 2020
ESMO 2020: Tisotumab Vedotin Shows Meaningful Clinical Activity in Cervical Cancer
Peter Hofland, Ph.D
-
September 21, 2020
ESMO 2020: Sacituzumab Govitecan Shows 27% ORR in Heavily-pretreated Metastatic Urothelial...
Editorial Team
-
September 20, 2020
ESMO 2020: First-in-class MK-4830 Antibody Targeting ILT4 Shows Promising Preliminary...
Editorial Team
-
September 20, 2020
ESMO 2020: Sotorasib Active in Patients with KRAS p.G12C Mutation –...
Editorial Team
-
September 20, 2020
1
...
20
21
22
...
24
Page 21 of 24
LATEST NEWS
US FDA Approves Gilead’s Sacituzumab Govitecan In Pre-treated HR+/HER2- Metastatic Breast Cancer
Editorial Team
-
February 3, 2023
World health Organization Launches a New Global Breast Cancer Initiative
Editorial Team
-
February 3, 2023
A New Design Improves CAR-based Immunotherapies
Editorial Team
-
February 2, 2023
Study: Blocking Immune Suppressor Cells in Mice with Glioblastoma Improves Survival
Danielle Garcia
-
January 27, 2023
Stephen Spellman: Mismatched Unrelated Donors – Key to Erasing the Gap in Donor Availability...
Editorial Team
-
January 18, 2023
X